BSEInsider Trading / SAST23 Jun 2026 · 23 Jun 2026, 04:04 pm

Intimation of Closure of Trading window for the quarter ended June 30, 2026

Godavari Drugs Ltd · 530317

✦ AI Summary

Godavari Drugs Ltd has announced the closure of its trading window for Designated Persons and their immediate relatives from July 1, 2026, until 48 hours after the declaration of un-audited financial results for the quarter ending June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, to prevent insider trading ahead of financial disclosures.

Analysis Scores

Earnings Impact5/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Godavari Drugs Ltd - 530317 - Closure of Trading Window

Attachments (1)

📄

bb0d7da0-6df7-402a-b69e-c19c075675aa.pdf

pdf

Download →
View document text
GODAVARI DRUGS LIMITED Regd. Off.:‘Mayfair’, S.P. Road, Secunderabad - 500 003. TS, India. Voice : +91-40-2784 9700 / 2784 2602 / 2784 4557 E-mail : info@godavaridrugs.com | Website : www.godavaridrugs.com 23.06.2026 CORPORATE RELATIONS DEPARTMENT, BSE LIMITED PHIROZE JEEJEEBHOY TOWERS DALAL STREET, MUMBAI- 400 001 Sub: Intimation of closure of trading window in terms of SEBI (Prohibition of Insider Trading Regulations, 2015 Scrip code: 530317 Dear Sir, It is hereby informed that pursuant to the provisions of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulation, 2015 read with Code of Conduct for Regulating, Monitoring and Reporting of Trading by Designated Persons as framed by the Company, the trading window for dealing in securities of the Company will remain closed for all Designated Persons and their immediate relatives from July 1, 2026 till 48 hours after declaration of the un- audited financial results of the Company for the quarter ending June 30, 2026 by the Company to the Stock Exchange. Accordingly all Connected/ Designated Persons and their relatives have been advised not to trade in the securities of the Company during the aforesaid period of closure of trading window. This is for your information and record. Thanking you. Thanking You Yours Sincerely For Godavari Drugs Limited Venkatesh Achanta Company Secretary & Compliance Officer Plant : A-6/2, MIDC, Nanded - 431 603. MS, India. E-mail : nnd@godavaridrugs.com CIN:L24230TG1987PLC008016